Guest User 12/4/15 Guest User 12/4/15

Canada shows a “disturbing” decline in innovation and R&D

Read the Canadian Business article on the recently released STIC report.

Guest User 12/3/15 Guest User 12/3/15

OBIO® MPP Health Science Caucus Launches Three Party Effort to Advance Industry

Toronto, Ontario, December 3, 2015 – OBIO announced today that MPPs from the three major parties have come together to work on policy initiatives to strengthen Ontario’s Health Science industry.

Guest User 11/20/15 Guest User 11/20/15

Dose of the Valley - Call for Applications

For the second year, the Consulate General of Canada in San Francisco and the Consulate of Canada in San Diego are pleased to host the Dose of the Valley program for the life sciences sector.

Guest User 11/20/15 Guest User 11/20/15

Launch of the second Canada-Chicago Mentoring Program (C2MP)

The Consulate General of Canada in Chicago successfully partnered in 2015 (testimonials included in our enclosed marketing document for the 2016 program) with the Chicago Innovation Mentors (CIM) to provide a comprehensive mentoring program for three Canadian life science and healthcare entrepreneurs.

It is our pleasure to announce that the program has been renewed for 2016. The Consulate will again be able to funnel three Canadian start-ups through CIM’s mentoring program.

Guest User 11/5/15 Guest User 11/5/15

Canada needs a strategy to reach its biotech potential

Canada has a well-known research sector and relatively strong infrastructure to nurture startups, but once biotech companies start to grow, they often stall and struggle for resources.

Guest User 11/4/15 Guest User 11/4/15

Ontario Bioscience Innovation Organization Announces Election of Shelley Boyd, Jeremy Bridge-Cook, Michael Cloutier and Cathy Szabo to its Board of Directors

Toronto, Ontario, November 4, 2015 – Ontario Bioscience Innovation Organization (“OBIO®”), a non-profit organization that is Ontario’s leading advocate for the life science sector, announces the election of four new members to its Board of Directors: Shelley Boyd, Jeremy Bridge-Cook, Michael Cloutier and Cathy Szabo.

Guest User 11/4/15 Guest User 11/4/15

Ontario Bioscience Innovation Organization Announces a Call for Applications for the 2016 Capital Access Advisory Program

Toronto, Ontario, November 3, 2015 – Ontario Bioscience Innovation Organization (OBIO®), a not-for-profit organization that is Ontario’s leading advocate for the life sciences sector, is pleased to announce a call for applications for the 2016 OBIO Capital Access Advisory Program (CAAP®).

Guest User 9/24/15 Guest User 9/24/15

Ontario Bioscience Innovation Organization Congratulates Ontario on the Appointment of Chief Health Innovation Strategist

Today, Ontario Bioscience Innovation Organization (OBIO®) released a statement congratulating the Government of Ontario on the appointment of William Charnetski as Ontario’s first Chief Health Innovation Strategist.

“OBIO congratulates Mr. Charnetski on his appointment to this pivotal role,” said Gail Garland, Chief Executive Officer of OBIO. “We look forward to supporting his efforts to catalyze adoption of innovative health technologies which strengthen the province’s capacity to deliver cost-effective, outcome-focused care for patients.”

obio 9/21/15 obio 9/21/15

OBIO Congratulates and Welcomes Johnson & Johnson Innovation, JLABS to the Ontario Bioscience Ecosystem

Toronto, Ontario, September 21, 2015 – The Ontario Bioscience Innovation Organization (OBIO®) is pleased to recognise Johnson & Johnson Innovation’s major contribution to Ontario’s human health bioscience ecosystem through the choice of Toronto as the first ex-US Johnson & Johnson Innovation, JLABS site. The JLABS incubator model is the highly successful creation of Johnson & Johnson Innovation and has been brought to Canada with the help of Janssen Inc. Known as JLABS @ Toronto, the site will join its fellow JLABS sites in San Diego, San Francisco, Boston and Houston.

obio 8/10/15 obio 8/10/15

Pre-Capital Access Advisory Program (Pre-CAAP)

OBIO Launches Pre-Capital Access Advisory Program (Pre-CAAP) – Builds on Successful Capital Access Advisory Program (CAAP™) Improving financing success of Ontario bioscience companies Toronto, Ontario, August 10, 2015 – Ontario Bioscience Innovation Organization (OBIO®) today announced the launch of the inaugural round of Pre-CAAP, a program in support of Ontario bioscience companies that aim to raise...

obio 5/23/15 obio 5/23/15

OBIO CAAP Program Receives FedDev Ontario Funding

Toronto, Ontario, May 22, 2015 – Ontario Bioscience Innovation Organization (OBIO®) today announced they have received an investment of up to $3.894 million from the Federal Economic Development Agency for Southern Ontario (FedDev Ontario) for OBIO®’s Capital Access Advisory Program (CAAP™).

“It is tremendous to see this practical support for commercializing health sciences and for building our human health bioscience industry,” said Gail Garland, President and CEO, OBIO®. “We are deeply grateful for this opportunity to expand our programming and help even more growing companies.”

obio 3/6/15 obio 3/6/15

2015 Healthcare Conferences

obio 2/23/15 obio 2/23/15

OBIO/OBEST Five Year Strategic Review: January 2015

Since its founding, the Ontario Bioscience Innovation Organization (OBIO®) has been engaged in creating the future of Ontario’s biomedical sector through industry-led strategy, policy development, advocacy and high impact programming.

obio 2/16/15 obio 2/16/15

Spectral to Present at the 20th International Conference on Advances in Critical Care Nephrology (AKI & CRRT) in San Diego

Spectral Medical Inc., a Phase III company developing the first therapy for patients with septic shock guided by a diagnostic, today announced that it will present at the upcoming 20th International Conference on Advances in Critical Care Nephrology (AKI & CRRT) conference in San Diego, California on February 18, 2015 during an interactive luncheon session.

obio 2/9/15 obio 2/9/15

Ontario Bioscience Innovation Organization Presents to Provincial Standing Committee on Finance and Economic Affairs

Toronto, Ontario, January 29, 2015 – The Ontario Bioscience Innovation Organization (“OBIO®”), Ontario’s leading advocate for the health science industry, is pleased to announce that OBIO was invited to present today to the Provincial Standing Committee on Finance and Economic Affairs.

obio 1/14/15 obio 1/14/15

Ontario Bioscience Innovation Organization Announces Election of Cynthia Goh, Ian Smith and Mark Steedman to its Board of Directors

Ontario Bioscience Innovation Organization (“OBIO®”), a non-profit organization that is Ontario’s leading advocate for the life science sector, announces the election of three new members to its Board of Directors: Cynthia Goh, Ian Smith and Mark Steedman.